Association between vitamin D receptor gene polymorphisms and breast cancer risk: A meta-analysis of 39 studies

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhang, Kai ^a   Song, Lihua ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN;

APA1 GENE; ARTICLE; BREAST CANCER; BSM1 GENE; CANCER RISK; FOK1 GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; POLY A GENE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TAQ1 GENE; TUMOR GENE; VDR GENE; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK;

EID: 84899713707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096125     Document Type: Article

References (55)

1. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27: 3757-3763.
2. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 70: 8587-8597.
3. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371.
4. Zerwekh JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87: 1087S-1091S.
5. Krishnan AV, Feldman D (2011) Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51: 311-336.
6. Guyton KZ, Kensler TW, Posner GH (2003) Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev 61: 227-238. (Pubitemid 37259932)
7. Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, et al. (1988) Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab 67: 607-613.
8. Berger U, McClelland RA, Wilson P, Greene GL, Haussler MR, et al. (1991) Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res 51: 239-244.
9. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, et al. (1999) Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 83: 723-726.
10. Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, et al. (2000) Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control 11: 25-30.
11. Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE (2005) Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2335-2339. (Pubitemid 41437833)
12. John EM, Schwartz GG, Koo J, Wang W, Ingles SA (2007) Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol 166: 1409-1419. (Pubitemid 350209052)
13. McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, et al. (2007) Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 9: R9.
14. Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, et al. (2008) Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 10: R31.
15. Sinotte M, Rousseau F, Ayotte P, Dewailly E, Diorio C, et al. (2008) Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population. Endocr Relat Cancer 15: 975-983.
16. McKay JD, McCullough ML, Ziegler RG, Kraft P, Saltzman BS, et al. (2009) Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 18: 297-305.
17. Anderson LN, Cotterchio M, Cole DE, Knight JA (2011) Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 20: 1708-1717.
18. Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, et al. (2012) Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 21: 1856-1867.
19. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB, et al. (2012) Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Breast Cancer Res Treat 132: 683-691.
20. Shahbazi S, Alavi S, Majidzadeh AK, Ghaffarpour M, Soleimani A, et al. (2013) BsmI but not FokI polymorphism of VDR gene is contributed in breast cancer. Med Oncol 30: 393.
21. Fuhrman BJ, Freedman DM, Bhatti P, Doody MM, Fu YP, et al. (2013) Sunlight, Polymorphisms of Vitamin D-related Genes and Risk of Breast Cancer. Anticancer Res 33: 543-551.
22. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, et al. (2004) Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 10: 5472-5481. (Pubitemid 39100485)
23. Li BQ, Wan LJ, Chen YF, Liu G (2010) Association of vitamin D receptor start codon polymorphism and breast cancer risk in Han nationality of North China. Shandong Medical Journal 50: 10-12.
24. Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, et al. (2013) Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women. PLoS One 8: e57967.
25. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, et al. (2007) Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 9: R84.
26. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, et al. (2009) Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev 32: 386-394.
27. Wedren S, Magnusson C, Humphreys K, Melhus H, Kindmark A, et al. (2007) Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 16: 1775-1783. (Pubitemid 47450507)
28. Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C, et al. (1998) Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol Res 10: 43-46. (Pubitemid 128740428)
29. Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS, et al. (2002) Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat 74: 1-7.
30. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N (2003) Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 35: 550-555. (Pubitemid 38129320)
31. Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, et al. (2004) Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 101: 264-269. (Pubitemid 38890828)
32. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, et al. (2005) Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41: 1164-1169. (Pubitemid 40725575)
33. VandeVord PJ, Wooley PH, Darga LL, Severson RK, Wu B, et al. (2006) Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women. Breast Cancer Res Treat 100: 103-107.
34. Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, et al. (1999) No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20: 2131-2135. (Pubitemid 29535315)
35. Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S (1999) Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 59: 2332-2334. (Pubitemid 29242278)
36. Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, et al. (2004) Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics 14: 239-245. (Pubitemid 38530515)
37. Liu DQ, Zhang HC, Zou TN, Zhang Y, Yang ZQ, et al. (2011) Association between the Genetic Polymorphisms of Vitamin D Receptor and Sporadic Breast Cancer Risk in Yunnan Women Journal of Kunming Medical University 32: 91-94.
38. Cui J, Shen K, Shen Z, Jiang F, Shen F (2001) [Relationship of vitamin D receptor polymorphism with breast cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18: 286-288.
39. Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW, et al. (2012) Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study. J Am Coll Surg 215: 652-657.
40. Huang YZ, Lu H, Bai YH, Chen YL, Zeng YX, et al. (2012) Relationship between Genotypes and Halpotypes of Vitamin D Receptor Gene and Breast Cancer Risk. Journal of Medical Research 41: 89-92.
41. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, et al. (2009) STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 6: e22.
42. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
43. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
44. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
45. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA (1995) A random-effects regression model for meta-analysis. Stat Med 14: 395-411.
46. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, et al. (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349. (Pubitemid 28146215)
47. Colston KW, Berger U, Coombes RC (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1: 188-191. (Pubitemid 19038805)
48. Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, et al. (1997) Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab 82: 118-122.
49. Tang C, Chen N, Wu M, Yuan H, Du Y (2009) Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 117: 391-399.
50. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, et al. (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29: 3511-3536.
51. Nejentsev S, Godfrey L, Snook H, Rance H, Nutland S, et al. (2004) Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene. Hum Mol Genet 13: 1633-1639. (Pubitemid 39136719)
52. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338: 143-156. (Pubitemid 39094759)
53. Morrison NA, Yeoman R, Kelly PJ, Eisman JA (1992) Contribution of transacting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A 89: 6665-6669.
54. Ingles SA, Haile RW, Henderson BE, Kolonel LN, Nakaichi G, et al. (1997) Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 6: 93-98. (Pubitemid 27069201)
55. Perna L, Butterbach K, Haug U, Schottker B, Muller H, et al. (2013) Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 22: 437-442.